Skip to main content
Premium Trial:

Request an Annual Quote

PerkinElmer to Use Incyte Data to Develop Microarrays

NEW YORK, Oct 4 – PerkinElmer (NYSE: PKI) has subscribed to Incyte Genomics’ (Nasdaq: INCY) LifeSeq Gold gene sequence database for use in developing microarray-based gene expression analysis technology, the companies said Wednesday.

Under the terms of the deal, Incyte will offer NEN Life Science Products, a PerkinElmer subsidiary, full use of its proprietary cDNA clone sets. In exchange, Incyte will receive royalties from the sales of microarrays the company develops. Incyte has also agreed to offer its biological expertise to NEN in development of focused arrays that study specific diseases and disease pathways.

“We are pleased to expand our network of collaborators to include NEN, a proven leader in the microarray field,” Roy Whitfield, Incyte’s CEO, said in a statement. “We are continuing to broadly license our information enabling researchers worldwide to understand the molecular basis of disease, and expedite the development of new medicines.”

The companies did not disclose the financial terms of the agreement.

In the past two months, Incyte has signed similar partnerships with several other gene chip manufacturers.

On Tuesday Incyte said it had licensed two of its patents to American Home Products (AHP) so the company could create gene expression data using Affymetrix GeneChip arrays.

In August Incyte granted Motorola’s (NYSE: MOT) BioChip Systems unit the licensing rights to use Incyte’s LifeSeq Gold database to develop gene chips.

Additionally, on July 31 Incyte announced it had licensed its Easy-to-Spot pre-assembled set of non-proprietary human and mouse clones to Amersham Pharmacia Biotech, the life sciences business of Nycomed Amersham (LSE: NAM; NYSE: NYE), for use in its gene expression microarray products.

Incyte's shares were down 1, or 2.7 percent, at 36 1/2 in afternoon trading. PerkinElmer was off 5 3/16, or 5 percent, at 97 15/16.

The Scan

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.

Researchers Retrace Key Mutations in Reassorted H1N1 Swine Flu Virus With Avian-Like Features

Mutations in the acidic polymerase-coding gene boost the pathogenicity and transmissibility of Eurasian avian-like H1N1 swine influenza viruses, a PNAS paper finds.

Genome Sequences Reveal Evolutionary History of South America's Canids

An analysis in PNAS of South American canid species' genomes offers a look at their evolutionary history, as well as their relationships and adaptations.

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.